Qube Research & Technologies (QRT)
PCVX icon

Qube Research & Technologies (QRT)’s Vaxcyte PCVX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1M Buy
363,205
+217,834
+150% +$11.8M 0.02% 889
2026
Q1 		$8.45M Sell
145,371
-61,719
-30% -$3.35M 0.01% 1380
2025
Q4 		$9.56M Sell
207,090
-346,759
-63% -$15.5M 0.01% 1377
2025
Q3 		$19.9M Sell
553,849
-255,681
-32% -$8.47M 0.02% 894
2025
Q2 		$26.3M Buy
+809,530
New +$26.5M 0.03% 737
2025
Q1 		– Sell
-77,274
Closed -$6.33M – 3784
2024
Q4 		$6.33M Buy
+77,274
New +$7.67M 0.01% 1359
2022
Q3 		– Sell
-13,820
Closed -$301K – 2877
2022
Q2 		$301K Buy
+13,820
New +$320K ﹤0.01% 1593

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PCVX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Vaxcyte (PCVX) stake by 150% in Q2 2026, buying an estimated $11.8M and bringing the position to 363,205 shares worth $21.1M. The position accounts for 0.02% of the portfolio, ranked #889.

Qube Research & Technologies (QRT) first reported a position in PCVX in Q2 2022 and has held it in 7 quarters since. The position peaked at $26.3M in Q2 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 363,205 shares of Vaxcyte worth $21.1M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 217,834 Vaxcyte shares in Q2 2026, an estimated $11.8M.
  • Vaxcyte made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #889 holding.
  • Qube Research & Technologies (QRT) first reported a position in Vaxcyte in Q2 2022 and has held it in 7 quarters since.
  • Qube Research & Technologies (QRT)'s Vaxcyte position peaked at $26.3M in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.